Literature DB >> 22753957

Feline leukemia and feline immunodeficiency virus in Canada - A comment.

Ed Doornenbal, Walt Ingwersen, Guillaume Cloutier.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22753957      PMCID： PMC3239163     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  13 in total

1.  The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report.

Authors:  James R Richards; Thomas H Elston; Richard B Ford; Rosalind M Gaskell; Katrin Hartmann; Kate F Hurley; Michael R Lappin; Julie K Levy; Ilona Rodan; Margie Scherk; Ronald D Schultz; Andrew H Sparkes
Journal:  J Am Vet Med Assoc       Date:  2006-11-01       Impact factor: 1.936

Review 2.  Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.

Authors:  Ruiyu Pu; James Coleman; James Coisman; Eiji Sato; Taishi Tanabe; Maki Arai; Janet K Yamamoto
Journal:  J Feline Med Surg       Date:  2005-02       Impact factor: 2.015

3.  Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates.

Authors:  R Pu; J Coleman; M Omori; M Arai; T Hohdatsu; C Huang; T Tanabe; J K Yamamoto
Journal:  AIDS       Date:  2001-07-06       Impact factor: 4.177

4.  Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.

Authors:  M Omori; R Pu; T Tanabe; W Hou; J K Coleman; M Arai; J K Yamamoto
Journal:  Vaccine       Date:  2004-12-02       Impact factor: 3.641

5.  Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.

Authors:  Hajime Kusuhara; Tsutomu Hohdatsu; Mayuko Okumura; Kayoko Sato; Yumi Suzuki; Kenji Motokawa; Tsuyoshi Gemma; Rie Watanabe; Chengjin Huang; Setsuo Arai; Hiroyuki Koyama
Journal:  Vet Microbiol       Date:  2005-07-01       Impact factor: 3.293

Review 6.  Efficacy and safety of a feline immunodeficiency virus vaccine.

Authors:  Chengjin Huang; Douglas Conlee; Jennifer Loop; Deborah Champ; Mike Gill; Hsien-Jue Steve Chu
Journal:  Anim Health Res Rev       Date:  2004-12       Impact factor: 2.615

7.  Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.

Authors:  Chengjin Huang; Douglas Conlee; Michael Gill; Hsien-Jue Steve Chu
Journal:  J Feline Med Surg       Date:  2010-02-18       Impact factor: 2.015

8.  Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada.

Authors:  F Reggeti; D Bienzle
Journal:  J Gen Virol       Date:  2004-07       Impact factor: 3.891

Review 9.  FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review.

Authors:  E W Uhl; T G Heaton-Jones; R Pu; J K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2002-12       Impact factor: 2.046

10.  Effect of dual-subtype vaccine against feline immunodeficiency virus infection.

Authors:  T Hohdatsu; S Okada; K Motokawa; C Aizawa; J K Yamamoto; H Koyama
Journal:  Vet Microbiol       Date:  1997-11       Impact factor: 3.293
View more
  2 in total

1.  Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.

Authors:  Paweł M Bęczkowski; Matthew Harris; Navapon Techakriengkrai; Julia A Beatty; Brian J Willett; Margaret J Hosie
Journal:  Vaccine       Date:  2015-01-19       Impact factor: 3.641

Review 2.  The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?

Authors:  Margaret J Hosie; Navapon Techakriengkrai; Paweł M Bęczkowski; Matthew Harris; Nicola Logan; Brian J Willett
Journal:  Vet Sci       Date:  2017-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.